| Record ID | ia:pharmacologicalt0005pakc |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/pharmacologicalt0005pakc/pharmacologicalt0005pakc_marc.xml |
| Download MARC binary | https://www.archive.org/download/pharmacologicalt0005pakc/pharmacologicalt0005pakc_meta.mrc |
LEADER: 03340cam 2200817 a 4500
001 ocm22451962
003 OCoLC
005 20200727195023.0
008 900911s1991 sz a b 001 0 eng
010 $a 90005365
040 $aDNLM/DLC$beng$cDLC$dNLM$dMUQ$dBAKER$dBTCTA$dYDXCP$dGEBAY$dZWZ$dOCLCO$dDEBBG$dOCLCQ$dUKMGB$dOCLCQ$dOCLCO$dOCLCA$dOCLCF$dOCLCA
016 7 $a9013140$2DNLM
016 7 $a006087326$2Uk
019 $a24109010
020 $a3805552149
020 $a9783805552141
035 $a(OCoLC)22451962$z(OCoLC)24109010
050 00 $aRC632.C26$bP36 1990
060 00 $aW1$bPR666GK v.5 1991
060 10 $aWJ 356$bP152p 1991
082 00 $a616.6/22061$220
100 1 $aPak, Charles Y. C.
245 10 $aPharmacological treatment of endocrinopathies :$bbone disease, kidney stones, and related disorders /$cCharles Y. Pak with contributions by Bruce Ettinger, Clare D. Edman, and Stanley Wallach.
260 $aBasel ;$aNew York :$bKarger,$c©1991.
300 $aviii, 141 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aProgress in basic and clinical pharmacology ;$vvol. 5
504 $aIncludes bibliographical references and index.
540 $aCurrent copyright fee: GBP36.40$c24\0.$5Uk
650 0 $aCalcium$xMetabolism$xDisorders$xChemotherapy.
650 0 $aCystinuria$xChemotherapy.
650 0 $aOsteoporosis$xChemotherapy.
650 0 $aKidneys$xCalculi$xChemotherapy.
650 2 $aCystinuria$xdrug therapy.
650 2 $aKidney Calculi$xdrug therapy.
650 2 $aOsteoporosis, Postmenopausal$xdrug therapy.
650 6 $aCalcium$xMétabolisme, Troubles du$xChimiothérapie.
650 6 $aCystinurie$xChimiothérapie.
650 6 $aOstéoporose$xChimiothérapie.
650 6 $aCalculs néphritiques$xChimiothérapie.
650 6 $aCystinurie.
650 7 $aOsteoporosis$xChemotherapy.$2fast$0(OCoLC)fst01048819
650 7 $aCystinurie$xTraitement médicamenteux.$2fmesh
650 7 $aCalculs rénaux$xTraitement médicamenteux.$2fmesh
650 7 $aOstéoporose$xTraitement médicamenteux.$2fmesh
650 7 $aFrau$2gnd
650 7 $aHarnsteinkrankheit$2gnd
650 7 $aOsteoporose$2gnd
650 7 $aPharmakotherapie$2gnd
650 7 $aZystinurie$2gnd
650 7 $aCalcium$xMétabolisme, Troubles du$xChimiothérapie.$2ram
650 7 $aCystinurie$xChimiothérapie.$2ram
650 7 $aOstéoporose$xChimiothérapie.$2ram
650 7 $aCalculs néphritiques$xchimiothérapie.$2ram
650 07 $aOsteoporose.$2swd
650 07 $aFrau.$2swd
776 08 $iOnline version:$aPak, Charles Y.C.$tPharmacological treatment of endocrinopathies.$dBasel ; New York : Karger, ©1991$w(OCoLC)643816347
830 0 $aProgress in basic and clinical pharmacology ;$vvol. 5.
856 $31850-9999$uhttp://www.karger.com/$xBLDSS
938 $aBaker & Taylor$bBKTY$c126.25$d126.25$i3805552149$n0001785317$sactive
938 $aBaker and Taylor$bBTCP$n90005365
938 $aYBP Library Services$bYANK$n2009808
029 1 $aAU@$b000007547852
029 1 $aGEBAY$b1495564
029 1 $aNLGGC$b066407613
029 1 $aNLM$b9013140
029 1 $aUKMGB$b006087326
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 55 OTHER HOLDINGS